The US Food and Drug Administration (FDA) has granted 510(k) clearance to 4DMedical’s non-contrast, computed tomography (CT)-based ventilation-perfusion imaging technology, CT:VQ, for respiratory ...
Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in ...
Educating physicians about ventilation-perfusion scanning as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23 percent decrease in patient exposure, according to a study ...
US FDA assent for 4D Medical’s CT VQ ventilation perfusion device described by the company as a “transformational milestone”. It all started in August when the lung scanning innovator inked a deal ...
Shares in 4D Medical have soared up to 33%, after the US FDA approved the company’s CT:VQ lung imaging test for ventilation perfusion. The news sent 4D shares soaring up to 40%. 4D Medical describes ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to CT LVAS, a software that provides information on patient lung function ...
Pulmonary embolism is one of the most misdiagnosed clinical conditions -- as many as 60% are found only on autopsy. Venous thrombosis of the pelvic and deep femoral veins is the major risk factor, ...
LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces U.S. Food and Drug Administration (FDA) 510(k) clearance for CT:VQ™, the world's first ...
It all started in August when the lung scanning innovator inked a deal with the giant ASX-listed Pro Medicus, involving a $10 million loan and the hint of other liaisons to come. On September 1, 4D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results